Huntington National Bank trimmed its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 25.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,725 shares of the semiconductor company’s stock after selling 1,254 shares during the period. Huntington National Bank’s holdings in Synopsys were worth $1,750,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently modified their holdings of SNPS. Vanguard Group Inc. raised its holdings in shares of Synopsys by 20.7% during the third quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company’s stock worth $8,970,415,000 after purchasing an additional 3,120,401 shares during the period. Victory Capital Management Inc. raised its holdings in shares of Synopsys by 238.8% during the third quarter. Victory Capital Management Inc. now owns 2,824,349 shares of the semiconductor company’s stock worth $1,393,506,000 after purchasing an additional 1,990,608 shares during the period. Coatue Management LLC acquired a new stake in shares of Synopsys during the third quarter worth $892,605,000. Capital Research Global Investors raised its holdings in shares of Synopsys by 226.6% during the third quarter. Capital Research Global Investors now owns 2,524,512 shares of the semiconductor company’s stock worth $1,245,533,000 after purchasing an additional 1,751,432 shares during the period. Finally, State Street Corp raised its holdings in shares of Synopsys by 20.6% during the third quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company’s stock worth $4,322,273,000 after purchasing an additional 1,493,912 shares during the period. 85.47% of the stock is owned by institutional investors and hedge funds.
Synopsys Stock Performance
Shares of SNPS opened at $475.62 on Friday. The firm has a 50-day moving average price of $459.53 and a 200 day moving average price of $454.45. The firm has a market capitalization of $91.07 billion, a PE ratio of 110.10, a P/E/G ratio of 3.94 and a beta of 1.25. The company has a quick ratio of 1.26, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 52-week low of $376.18 and a 52-week high of $651.73.
More Synopsys News
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Synopsys said demand for AI chip design software is driving stronger business momentum, and it raised its annual forecast as a result. Synopsys raises annual forecast on demand for AI chip design software
- Positive Sentiment: The CFO highlighted that AI companies are increasingly using custom computer designs, a trend that could expand demand for Synopsys’ chip-design tools. AI Computer Design Diversity A Boon For Synopsys, Says CFO
- Positive Sentiment: Analysts raised price targets after the earnings report, signaling confidence in Synopsys’ longer-term growth outlook despite the stock’s recent weakness. Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Positive Sentiment: Synopsys also showcased new AI and multi-die design capabilities with Samsung Foundry, underscoring its role in advanced chip development. Synopsys Advances Power and Performance for AI and Multi-Die Designs on Latest Samsung Foundry Processes at SAFE Forum 2026
- Neutral Sentiment: The company beat fiscal Q2 estimates, with revenue up 41.9% year over year and EPS above expectations, but the market still sold the stock after the report. Synopsys Was the Worst S&P 500 Stock Thursday Despite Earnings Beat With AI and Merger in Focus
- Negative Sentiment: Investors appear wary about the company’s chip-IP business and the broader impact of integrating Ansys, which may be weighing on sentiment even after strong results. Synopsys slides even as Q2 results, guidance top estimates; adds activist to board
Analyst Upgrades and Downgrades
SNPS has been the topic of a number of analyst reports. Robert W. Baird set a $558.00 price objective on shares of Synopsys in a report on Thursday. Rosenblatt Securities increased their price objective on shares of Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a report on Tuesday. Citigroup increased their price objective on shares of Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday. BNP Paribas Exane increased their price objective on shares of Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a report on Thursday. Finally, Stifel Nicolaus increased their price objective on shares of Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday. Nine investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $563.81.
Check Out Our Latest Report on Synopsys
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
